Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond

Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750 · see citing works

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population

Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · see citing works

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works

Association of cardiometabolic multimorbidity with mortality

Di Angelantonio, E., Kaptoge, S., Wormser, D., Willeit, P., Butterworth, A. S., Bansal, N., O’Keeffe, L. M., Gao, P., Wood, A. M., Burgess, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.7008 · Cited by 1,155 · see citing works

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116 · see citing works

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115 · see citing works

The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine

Elliott, P., Peakman, T. C., & Biobank, O. B. O. U. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym276 · Cited by 996 · see citing works

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works

Loss-of-Function Mutations in <i>APOC3</i> and Risk of Ischemic Vascular Disease

Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919 · see citing works

Global epidemiology of dyslipidaemias

Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00541-4 · Cited by 882 · see citing works

Mendelian randomization of blood lipids for coronary heart disease

Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/eht571 · Cited by 748 · see citing works

Association of Triglyceride-Lowering <i>LPL</i> Variants and LDL-C–Lowering <i>LDLR</i> Variants With Risk of Coronary Heart Disease

Ference, B. A., Kastelein, J. J. P., Ray, K. K., Ginsberg, H. N., Chapman, M. J., Packard, C. J., Laufs, U., Oliver-Williams, C., Wood, A. M., Butterworth, A. S., et al. (2019) · JAMA · doi:10.1001/jama.2018.20045 · Cited by 724 · cited 1× · see citing works

Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe

Mika Kivimaki, B., Kuosma, E., Ferrie, J. E., Luukkonen, R. A., Nyberg, S. T., Alfredsson, L. S., Batty, G. D., Brunner, E. J., Fransson, E. I., Goldberg, M., et al. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30074-9 · Cited by 695 · see citing works

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation

Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692 · see citing works

Genome-wide genetic data on ~500,000 UK Biobank participantsPreprint

Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/166298 · Cited by 606 · see citing works

Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction

Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588 · see citing works

Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease

Castañer, O., Pintó, X., Subirana, I., Amor, A. J., Ros, E., Hernáez, Á., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Estruch, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.008 · Cited by 540 · see citing works

Inactivating Variants in <i>ANGPTL4</i> and Risk of Coronary Artery Disease

Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497 · see citing works

Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study

Han, Y., Hu, Y., Yu, C., Guo, Y., Pei, P., Yang, L., Chen, Y., Du, H., Sun, D., Pang, Y., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab413 · Cited by 480 · see citing works

Hypertriglyceridaemia and risk of coronary artery disease

Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 386 · see citing works

Instrumental Variable Estimation of Causal Risk Ratios and Causal Odds Ratios in Mendelian Randomization Analyses

Palmer, T., Sterne, J. A. C., Harbord, R. M., Lawlor, D. A., Sheehan, N. A., Meng, S., Granell, R., Smith, G. D., & Didelez, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr026 · Cited by 326 · see citing works

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315 · see citing works

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Gordts, P. L. S. M., Nock, R., Son, N.-H., Ramms, B., Lew, I., Gonzales, J. C., Thacker, B. E., Basu, D., Lee, R. G., Mullick, A. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86610 · Cited by 274 · cited 1× · see citing works

UK Biobank: Opportunities for cardiovascular research

Littlejohns, T. J., Sudlow, C., Allen, N. E., & Collins, R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehx254 · Cited by 270 · see citing works

Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease

Chait, A., Ginsberg, H. N., Vaisar, T., Heinecke, J. W., Goldberg, I. J., & Bornfeldt, K. E. (2020) · Diabetes · doi:10.2337/dbi19-0007 · Cited by 229 · see citing works

Collider Bias

Holmberg, M. J., & Andersen, L. W. (2022) · JAMA · doi:10.1001/jama.2022.1820 · Cited by 229 · see citing works

Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality

Wadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac822 · Cited by 209 · see citing works

Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction

Varbo, A., & Nordestgaard, B. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab293 · Cited by 174 · see citing works

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus

Hu, X., Liu, Q., Guo, X., Wang, W., Yu, B., Liang, B., Zhou, Y., Dong, H., & Lin, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01554-0 · Cited by 158 · see citing works

Parametric multistate survival models: Flexible modelling allowing transition‐specific distributions with application to estimating clinically useful measures of effect differences

Crowther, M. J., & Lambert, P. C. (2017) · Statistics in Medicine · doi:10.1002/sim.7448 · Cited by 150 · see citing works

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

Varbo, A., & Nordestgaard, B. G. (2019) · Annals of Neurology · doi:10.1002/ana.25432 · Cited by 145 · see citing works

Ambient air pollution associated with incidence and dynamic progression of type 2 diabetes: a trajectory analysis of a population-based cohort

Wu, Y., Zhang, S., Qian, S. E., Cai, M., Li, H., Wang, C., Zou, H., Chen, L., Vaughn, M. G., McMillin, S. E., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02573-0 · Cited by 132 · see citing works

Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm

Harrison, S. C., Holmes, M. V., Burgess, S., Asselbergs, F. W., Jones, G. T., Baas, A. F., Hof, F. N. G. V. ’., de Bakker, P. I. W., Blankensteijn, J. D., Powell, J. T., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4293 · Cited by 131 · see citing works

Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

Ridker, P. M., Rifai, N., MacFadyen, J., Glynn, R. J., Jiao, L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Tardif, J.-C., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059410 · Cited by 131 · see citing works

Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction

Doi, T., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.384 · Cited by 129 · see citing works

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study

Kaltoft, M., Langsted, A., & Nordestgaard, B. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa172 · Cited by 122 · see citing works

What is ‘remnant cholesterol’?

Stürzebecher, P. E., Katzmann, J. L., & Laufs, U. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac783 · Cited by 116 · see citing works

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

Duran, E. K., & Pradhan, A. D. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 108 · see citing works

Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study

Huh, J. H., Han, K.-D., Cho, Y. K., Roh, E., Kang, J. G., Lee, S. J., & Ihm, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01667-6 · Cited by 106 · see citing works

Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance

Silva, N. M. G. D., Freathy, R. M., Palmer, T., Donnelly, L. A., Luan, J., Gaunt, T. R., Langenberg, C., Weedon, M. N., Shields, B. M., Knight, B. A., et al. (2011) · Diabetes · doi:10.2337/db10-1317 · Cited by 91 · see citing works

Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study

Zhao, Y., Li, Y., Zhuang, Z., Song, Z., Wang, W., Huang, N., Dong, X. Y., Xiao, W., Jia, J., Liu, Z., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05761-y · Cited by 81 · see citing works

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

Lotta, L. A., Stewart, I. D., Sharp, S. J., Day, F. R., Burgess, S., Luan, J., Bowker, N., Cai, L., Li, C., Wittemans, L. B. L., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2866 · Cited by 78 · see citing works

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Shang, Y., Nasr, P., Widman, L., & Hagström, H. (2022) · Hepatology · doi:10.1002/hep.32519 · Cited by 69 · see citing works

Avoiding collider bias in Mendelian randomization when performing stratified analyses

Coscia, C., Gill, D., Benítez, R., Pérez, T., Malats, N., & Burgess, S. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00879-0 · Cited by 52 · see citing works

Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults

Oelrich, B., Dewell, A., & Gardner, C. D. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.06.003 · Cited by 41 · see citing works

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics

Gordillo‐Marañón, M., Zwierzyna, M., Charoen, P., Drenos, F., Chopade, S., Shah, T., Engmann, J., Casas, J. P., Chaturvedi, N., Papacosta, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25731-z · Cited by 32 · see citing works

Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity

Innes, H. A., Crooks, C. J., Aspinall, E., Card, T. R., Hamill, V., Dillon, J. F., Guha, I. N., Hayes, P. C., Hutchinson, S. J., West, J., et al. (2021) · Hepatology · doi:10.1002/hep.32123 · Cited by 31 · see citing works

Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies

Szili‐Török, T., Sokooti, S., Osté, M. C. J., Neto, A. W. G., Dullaart, R. P. F., Bakker, S. J. L., & Tietge, U. J. F. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01475-y · Cited by 24 · see citing works

Triglyceride Metabolism Modifies Lipoprotein(a) Plasma Concentration

Ramos-Cáceres, M., Lamíquiz-Moneo, I., Cenarro, A., Calmarza, P., Marco-Benedí, V., Bea, A. M., Mateo‐Gállego, R., Puzo, J., Ordovás, J. M., Civeira, F., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac412 · Cited by 19 · see citing works

The impact of alcoholic drinks and dietary factors on epigenetic markers associated with triglyceride levels

Lai, C., Parnell, L. D., Lee, Y., Zeng, H., Smith, C. E., McKeown, N. M., Arnett, D. K., & Ordovás, J. M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1117778 · Cited by 15 · see citing works

Associations of Changes in Blood Lipid Concentrations with Changes in Dietary Cholesterol Intake in the Context of a Healthy Low-Carbohydrate Weight Loss Diet: A Secondary Analysis of the DIETFITS Trial

Vergara, M., Hauser, M. E., Aronica, L., Rigdon, J., Fielding‐Singh, P., Shih, C. W., & Gardner, C. D. (2021) · Nutrients · doi:10.3390/nu13061935 · Cited by 4 · see citing works

Analytic codes for Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Zhao, Y. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10560861 · Cited by 1 · see citing works

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018

Lai, H., Tu, Y., Liao, C., Zhang, S., He, L., & Li, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02667-y · Cited by 61 · see citing works

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

Cummings, B. B., Joing, M. P., Bouchard, P. R., Milton, M. N., Moesta, P. F., Ramanan, V., Lane, A., Hirman, J., Trauger, J. W., Maratos-Flier, E., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00825-6 · Cited by 49 · see citing works

Transport functions of intestinal lymphatic vessels

Tso, P., Bernier‐Latmani, J., Petrova, T. V., & Liu, M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00996-z · Cited by 33 · see citing works

Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)

Strandberg, T. E., Kovanen, P. T., Lloyd‐Jones, D. M., Raal, F. J., Santos, R. D., & Watts, G. F. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02089-0 · Cited by 29 · see citing works

[Incisional hernia after surgery for abdominal aortic aneurysm].

Augestad, K. M., Wilsgaard, T., & Solberg, S. K. (2002) · PubMed · Cited by 29 · see citing works

Interactions between lipid droplets and mitochondria in metabolic diseases

Wang, G., Sun, B., Liu, H., Hu, M., Xu, H., Li, H., Wang, X., & Tong, M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02759-4 · Cited by 32 · see citing works

The Cardioprotective Effects of Polyunsaturated Fatty Acids Depends on the Balance Between Their Anti- and Pro-Oxidative Properties

Sidorkiewicz, M. (2024) · Nutrients · doi:10.3390/nu16223937 · Cited by 28 · see citing works

Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation

Li, D., Lin, J., Yang, H.-X., Zhou, L.-H., Li, Y.-J., Xu, Z., Sun, L., Zhang, X.-Y., Xu, W.-L., & Wang, Y.-G. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02790-w · Cited by 28 · see citing works

Dietary medium-chain triacylglycerols in metabolic regulation

Cao, Y., Kanta, J. M., Bishop, C. A., Kiens, B., Fritzen, A. M., & Kleinert, M. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.010 · Cited by 25 · see citing works

Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)

Wulff, A. B., & Nordestgaard, B. G. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf274 · Cited by 22 · see citing works

Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes

Elías-López, D., Wadström, B. N., Vedel‐Krogh, S., Kobylecki, C. J., & Nordestgaard, B. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01555-1 · Cited by 18 · see citing works

Aging and Sex Modify the Risk of Carotid Plaque Thrombosis Related to Dyslipidemic Profile

Servadei, F., Scimeca, M., Palumbo, V., Oddi, F. M., Bonfiglio, R., Giacobbi, E., Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., et al. (2025) · Stroke · doi:10.1161/strokeaha.125.051754 · Cited by 18 · see citing works

Life’s essential 8 and progression of cardiometabolic multimorbidity trajectory: a prospective study of UK biobank

Huang, M., Fu, R., Zhao, X., Liu, T., Li, X., & Jiang, W. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf247 · Cited by 15 · see citing works

Association between cardiorenal syndrome and depressive symptoms among the US population: a mediation analysis via lipid indices

Yu, G., Liu, L., Ma, Q., & He, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02356-x · Cited by 11 · see citing works

Association between physical activity-related metabolic signature and cardiometabolic diseases and multimorbidity: A cohort study from UK biobank

Wang, J., Zheng, Y., Jiang, Y., Suo, C., Zhang, T., Chen, X., & Xu, K. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108211 · Cited by 11 · see citing works

Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease

Borén, J., Packard, C. J., Nordestgaard, B. G., & Catapano, A. L. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf214 · Cited by 12 · see citing works

Biomarkers of multimorbidity: A systematic review

Zazzara, M. B., Triolo, F., Biscetti, L., Paparazzo, E., Fiorillo, M., Vetrano, D. L., & Onder, G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102870 · Cited by 12 · see citing works

Association between the cumulative atherogenic index of plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body mass index

He, Q., Yu, W., Rao, X., Lin, D., You, Y., Yan, L., Liang, W., Hua, F., Guan, X., & Wang, X. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02875-9 · Cited by 9 · see citing works

Remnant cholesterol elevates hyperuricemia risk in the middle aged and elderly Chinese: a longitudinal study

Ma, J., Xu, F., & Zhang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-75951-8 · Cited by 8 · see citing works

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cognitive impairment in patients with acute mild ischemic stroke

Wang, H., Wang, J., Feng, D., Wang, L., & Zhang, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02693-2 · Cited by 8 · see citing works

Remnant cholesterol and body mass index jointly associate with cardiometabolic Multimorbidity with mediation analysis in CHARLS a prospective cohort study

Li, J., Fan, M., Yang, M., Huang, W., Shi, W., Zhang, D., Zhu, W., Liu, C., Xu, N., Zhang, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25958-6 · Cited by 8 · see citing works

Association between the CHG index and cardiometabolic multimorbidity: a nationwide prospective cohort and multi-community cross-sectional study

Liu, L., Meng, Y., Hu, L., Runa, A., Zhang, Y., & Gao, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1725495 · Cited by 8 · see citing works

Investigating the impact of extreme weather events and related indicators on cardiometabolic multimorbidity

Wu, D., Shi, Y., Wang, C., Li, C., Lu, Y., Wang, C., Zhu, W., Sun, T., Han, J., Zheng, Y., et al. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01361-x · Cited by 7 · see citing works

Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study

Wang, D., Zhang, Z., Zhang, Y., Chen, S., Qu, N., Li, H., Sun, Y., Tian, X., Han, X., Wu, S., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038559 · Cited by 7 · see citing works

Cumulative average remnant cholesterol inflammatory index and risk of cardiometabolic multimorbidity: evidence from a prospective nationwide cohort study in China

Zhang, W., Jing, C., Liu, X., & Hou, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-025-02850-w · Cited by 7 · see citing works

The association between triglyceride glucose-frailty index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study

Hou, X., Wang, G., & Gao, Y. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03191-3 · Cited by 7 · see citing works

Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology

Miyake, T., Furukawa, S., Matsuura, B., Yoshida, O., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Okazaki, Y., Nakamura, Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae597 · Cited by 7 · see citing works

Association of C-reactive protein-triglycerides-glucose index-waist to height ratio and cardiometabolic multimorbidity in middle-aged and older adults: a nationwide cohort study

Du, J., Man, Z., Bai, X., Luo, D., Guo, Q., Wang, Y., Yan, Y., Su, X., & Zheng, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03151-x · Cited by 6 · see citing works

The prognostic role of remnant cholesterol in Asian menopausal women received percutaneous coronary intervention with acute coronary syndrome

Feng, X., Liu, Y., Yang, J., Zhou, Z., Yang, S., Zhou, Y., & Guo, Q. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02258-y · Cited by 6 · see citing works

The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in East Asians

Lin, C., Wen, H., Yu, M., Huang, Q., Wang, Q., Lin, J., Yang, W., Wong, J. M. J., Xia, M., Tang, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04329-y · Cited by 5 · see citing works

The correlation between different metabolic scores and the risk of cardiometabolic comorbidities in hypertensive patients

Muheiyati, G., Wang, J., Chen, X., Guan, X., An, H., & Tao, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-01963-7 · Cited by 5 · see citing works

A cross-sectional analysis of remnant cholesterol-diabetes association in US adults

Li, X., Cui, G., & Xuemin, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-10961-8 · Cited by 5 · see citing works

Exercise-imitating adipocyte targeted poly-Lipidic DendroRNAi Nanovesicles for gene silencing-guided treatment of obesity in high-fat diet mouse model

Vasdev, N., Gupta, T., Bain, A., Mishra, M., Sahu, R., Pawar, B., & Tekade, R. K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146217 · Cited by 5 · see citing works

Shared genetic architecture between stroke and blood lipids: a large-scale genome-wide cross-trait analysis

Bai, W., Zhou, G., Jiang, H., Li, X., & Shao, J. (2025) · Human Genomics · doi:10.1186/s40246-025-00789-8 · Cited by 4 · see citing works

Diagnostic efficacy of remnant cholesterol inflammatory index in diabetic kidney disease: machine learning approaches

Xie, X., Li, X., Li, H., Gao, Y., Zhao, F., & Chen, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1642358 · Cited by 4 · see citing works

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study

Roh, E., Heo, J. H., Jung, H. N., Han, K., Kang, J. G., Lee, S. J., & Ihm, S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0406 · Cited by 4 · see citing works

Association of Cumulative Exposure to Triglyceride and Remnant Cholesterol With the Risk of Cardiovascular Disease in Hypertensive Patients With Target LDL‐C

Guo, S., Wang, C., Hu, T., Lan, L., Ge, Z., Huang, J., Chen, S., Wu, S., & Xue, H. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70084 · Cited by 4 · see citing works

Effect of plasma homocysteine on cardiometabolic multimorbidity among Chinese adults: a population-based and real-world evidence study

Li, L., Wang, J., Li, J., Li, M., Wang, J., Long, T., Zhengliu, Y., Tan, X., Peng, Y., & Hong, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1522212 · Cited by 4 · see citing works

Analysis of Metabolic Risk Factors for Microcirculation Disorders Post-Percutaneous Coronary Intervention and Predictive Model Construction: A Study on Patients with Unstable Angina

Li, K., Liu, S., Wang, J., Liu, Z., & Qi, C. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25739 · Cited by 4 · see citing works

Remnant cholesterol in early pregnancy as a predictor of gestational diabetes mellitus beyond triglyceride levels: a retrospective cohort study

Li, X.-X., Zhang, J.-Y., Chen, S.-Y., Wu, X., Ma, C., & Shen, H. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07871-y · Cited by 3 · see citing works

Spirometric patterns associated with the progression of cardiometabolic diseases in middle-aged and older adults: A prospective cohort study

Wang, N., Shi, X., Wang, T., Jia, X., Fan, Z., Yang, C., Wang, Y., Fan, J., Zhao, C., Niu, Y., et al. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108689 · Cited by 3 · see citing works

Redefining the association of triglycerides with all-cause and Cardiovascular Disease Mortality in the Chinese population: a nationwide, population-based, prospective cohort study of 3.8 million Chinese adults

Li, G., He, L., Bai, X., Chen, S., Dai, H., He, G., Yang, Y., Zhang, X., Cui, J., Li, X., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101689 · Cited by 3 · see citing works

Metabolic dysfunction associated steatotic liver disease, cardiometabolic multimorbidity and mortality: evidence from the UK biobank

Shen, C., Yang, R., Zhou, Y., Cheng, Y., Cheng, Y., Yao, Y., Lv, Y., Zeng, R., Zhao, Q., Jia, Y., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02845-2 · Cited by 3 · see citing works

Accelerometer-Derived Physical Activity Associated With Incidence and Progression Trajectory of Cardiometabolic Multimorbidity

Shen, F., Liu, H.-Y., Liu, Y., Yang, J., Zhang, L.-W., Li, Q.-M., Liu, L., Gong, T.-T., Wu, Q., & Gao, S. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.11.020 · Cited by 3 · see citing works

Associations of TyG-Derived Indices with Cardiometabolic Multimorbidity Risk in Community-Dwelling Older Adults: A Longitudinal Analysis Based on the GOLD-Health Cohort

Liao, C., Liu, H. T., Xu, S., Ling, Z., Zhuo, Y., Huang, G., Lin, W., & Zhang, Z. (2026) · Nutrients · doi:10.3390/nu18060985 · Cited by 3 · see citing works

Longitudinal cohort study on the dynamic changes of atherogenic index of plasma and the risk of cardiometabolic multimorbidity in middle - aged and elderly people

Hu, L., & Zhao, Z. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05387-z · Cited by 3 · see citing works

Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China Health and Retirement Longitudinal Study (CHARLS)

Feng, X., Bi, D., Pan, Y., Liu, K., Lei, W., Tang, X., & Xia, J. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03235-8 · Cited by 3 · see citing works

Elevated remnant cholesterol predicts poor outcome in patients with premature acute coronary syndrome: a retrospective, single-center study

Zhang, M., Chen, J., Xia, W. T., Yu, Z., Zhang, C., Wang, W., Shao, Y., & Wang, B. (2025) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-025-03147-6 · Cited by 3 · see citing works

Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status

Chero‐Sandoval, L., Higuera‐Gómez, A., Martínez‐Urbistondo, M., Castejón, R., Mellor‐Pita, S., Moreno‐Torres, V., de Luis, D. A., Cuevas‐Sierra, A., & Martínez, J. A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14339 · Cited by 3 · see citing works

Obesity-depression-metabolism triad: amplification of cardiometabolic multimorbidity risk in Chinese adults (CHARLS 2011–2018)

He, Q., Wen, Y., Long, C., Lin, D., Lu, F., Zhong, M., Lin, W., Huang, S., Hua, S., Hua, F., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02724-1 · Cited by 3 · see citing works

The relationship between remnant cholesterol and young-onset myocardial infarction in patients with type 2 diabetes: a retrospective study

Gao, Y., Lei, T., Dang, P., & Li, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1512662 · Cited by 2 · see citing works

Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement

Sampath-Kumar, R., Padilla, E., Wilkinson, M. J., Barba, D. T., Aramburo, N., Mahmud, E., Ben‐Yehuda, O., & Taub, P. R. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102247 · Cited by 2 · see citing works

The role of instrumental activity of daily living disability in the association between circadian syndrome and cardiometabolic multimorbidity in Chinese middle-aged and older adults

Fang, Y., Wu, D., Shi, Z., Shen, J., Liu, E., Wu, X., Hu, W., & Lv, L. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01118-4 · Cited by 2 · see citing works

Life’s Essential 8 and healthy longevity among people with and without cardiometabolic multimorbidity: A prospective study of UK Biobank

Huang, M., Fu, R., Zhao, X., Liu, T., Li, X., & Jiang, W. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101433 · Cited by 2 · see citing works

Remnant cholesterol inflammatory index and mortality in cardiovascular-kidney-metabolic syndrome: a national study

Wang, L., Li, H., Wang, L., Hao, J., Zhang, Q., Zhou, Q., Wang, J., & Qi, C. (2026) · Archives of Medical Science · doi:10.5114/aoms/218809 · Cited by 2 · see citing works

Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee

Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3 · see citing works

Enhancing decision support for type 2 diabetes mellitus comorbidity risk prediction: An end-to-end multi-task learning model

Yue, J., Luo, L., Guo, M., & Xu, C. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.128816 · Cited by 2 · see citing works

Triglyceride levels and remnant cholesterol triglyceride-rich lipoproteins in metabolic syndrome and diabetes

Симонова, Г. И., Щербакова, Л. В., Malyutina, S. K., Каширина, А. П., & Ragino, Y. I. (2024) · Ateroscleroz · doi:10.52727/2078-256x-2024-20-3-326-344 · Cited by 1 · see citing works

Effects of remnant cholesterol on adverse renal outcomes in lupus nephritis

Shi, X., Zhang, X., Lu, Y., Xiang, W., Wang, X., Yu, J., Ye, H., Wu, H., Tang, R., Xia, X., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02503-y · Cited by 1 · see citing works

Association between Remnant Cholesterol and Metabolic Syndrome beyond Conventional Lipid Parameters in Middle Age and Elderly Population: Bushehr Elderly Health (BEH) cohort

Esmaeili, S., Fahimfar, N., Esmaeili, B., Rezaei–Tavirani, M., Razi, F., & Bandarian, F. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01692-8 · Cited by 1 · see citing works

Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: evidence from a population-based retrospective cohort study

Hsieh, H., Tien, N., Lin, C., Wong, W.-H., Lee, W.-Y., Chen, C., Tsai, F., You, B., Fang, Y., & Lim, Y.-P. (2025) · European journal of medical research · doi:10.1186/s40001-025-03130-0 · Cited by 1 · see citing works

Purified Anthocyanins Indicated No Significant Effect on Arterial Stiffness, Four-Limb Blood Pressures and Cardiovascular Risk—A 12-Week Dose–Response Trial in Chinese Middle-Aged and Elderly Adults with Hyperglycemia

Liu, Z., Li, M., Chen, Y., Wang, C., Chen, J., Long, H., Liu, R., Chiou, J. A., & Chen, C. (2025) · Nutrients · doi:10.3390/nu18010112 · Cited by 1 · see citing works

Data-driven glycolipid network phenotypes reveal a graded risk spectrum for cardiometabolic multimorbidity: a prospective study in middle-aged and older Chinese adults

Lu, Z., Dong, B.-Q., Chen, L., Wei, H., & Zhang, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02894-6 · Cited by 1 · see citing works

Association between remnant cholesterol and stroke among patients with atrial fibrillation: A population-based cohort study

Li, Y., Ling, Y., Wu, H., Luo, S., Luo, J., Tang, X. W., Li, S., Zhuang, X., Wu, B., Xiong, Z., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.02.020 · Cited by 1 · see citing works

Causal statistical association between remnant cholesterol and coronary heart disease: genetic insights into the PSRC1–CELSR2–SORT1 gene cluster

Han, G., Lei, C. L., Shi, Y., Gao, J., Liu, X., Peng, K., Cai, Y., Hoi, P. M., & Yichong, L. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101047 · Cited by 1 · see citing works

Cholesterol metabolism dysregulated by key HBV mutations revealed through multi-omics profiling

Chen, Y., Lin, P., Jin, J., Deng, M., & Wei, D. (2026) · iScience · doi:10.1016/j.isci.2026.115844 · Cited by 1 · see citing works

Genetically determined very low lipoprotein(a) is not associated with type 2 diabetes and glycemic traits

Lee, M. P., Baca, P., Rivas, F., Zhang, A., Alegre-Díaz, J., Berumen-Campos, J., Kuri-Morales, P., North, K. E., Rodriguez, C. J., Stürmer, T., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101716 · Cited by 1 · see citing works

Association of pyridoxal 5′-phosphate (PLP) with lipid profiles: a population-based cohort study

Zhang, R., Chen, Y., Yan, X.-Q., Zhang, Y., Zhou, H. K., & Feng, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1545301 · Cited by 1 · see citing works

Apolipoprotein A1 and Lipoprotein(a) as Biomarkers for the “Penumbra Freezing” in Acute Ischemic Stroke: Insights From a Case-Control and Mendelian Randomization Study

Liu, J., Xu, Z., Wen, Y., Guo, X., Chen, X., Liu, D., Li, L., & Liu, H. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673374444250901100551 · Cited by 1 · see citing works

Targeting triglycerides for cardiovascular risk reduction

Maiorca, C., Tramontano, D., Di Costanzo, A., & D’Erasmo, L. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04383-1

Remnant Cholesterol as a Predictor of Cardiovascular Outcomes in Acute Coronary Syndrome Patients with Low-Density Lipoprotein Cholesterol Levels Below 1.8 mmol/L: Insights from the MPCS-ACS StudyPreprint

Yang, H.-T., Yang, Y., Liu, J., Zhang, J., & Zhang, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4856821/v1

Impact of Smoking and Physical Activity on Total Cholesterol Levels, Lipoproteins, and Coronary Heart Disease Risk :Statistical Evidence.

Babiker, M. A., & Elsayir, H. A. (2024) · Nanotechnology Perceptions · doi:10.62441/nano-ntp.vi.3670

Non-linear relationship between the atherogenic index of plasma and ischemic stroke in the diabetic population in ICU: A multicenter retrospective cohort studyPreprint

Wu, L., Su, Z., Chen, X., Hu, H., & Wan, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-5638991/v1

Demystifying the nuances of the lipid patient: a guide for primary care providers

Myerson, M. L., Gillett, K., O’Hara, J., Potter, R., & SKOLNIK, N. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101070

Elevated remnant cholesterol impairs sleep characteristics in individuals with newly diagnosed moderate-to-severe obstructive sleep apnea: a cross-sectional case–control study

Liu, Y., Zhang, F., Zhang, P., & Chen, L. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1648807

Postprandial metabolism of a reduced-fat meat product with added silicon from diatomaceous earth. A pilot randomized controlled four-way assay in humans

Vaquero, M. P., Álvarez, M. D., Zapatera, B., Saiz, A., & Cofrades, S. (2025) · Food & Function · doi:10.1039/d5fo00973a

Non-Traditional Lipid Ratios Predict Cardiovascular-Kidney-Metabolic Syndrome: Insights from Machine Learning Model Using NHANES DataPreprint

Wang, N., Zhang, J., Wang, Y., Zhang, X., Shi, Y., Zhang, L., Xing, Y., & Lv, Q. (2025) · medRxiv · doi:10.1101/2025.09.26.25336774

Multimorbidity quantification from the perspective of precision management: challenges and strategies

Huang, X., Guo, X., Gan, Y., Xu, A., Sun, K., Shen, H., Niu, Z., Zhang, Y., Guo, Y., Ma, Y., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2569988

Association of cumulative inflammation index with order of onset and long-term risk of cardiometabolic multimorbidity and depressive Symptoms: A prospective cohort study

Jiang, M., Li, X., & Lu, Y. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106157

Liquid/liquid interfacial plasmonic array for ultrasensitive cholesterol monitoring in complex dairy matrices

Du, S., & Liu, Z. (2025) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2025.108582

Beyond cardiovascular disease: remnant cholesterol as a novel risk factor for osteoarthritis

Xie, R., Chen, Z., Zhang, G., & Zhao, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1692833

Long-term body mass index variability and the risk of cardiometabolic multimorbidity in middle-aged and older adults: Insights from two prospective cohorts

Ren, X., Yang, M., Tian, J., Chang, X., Wang, G., & Liu, J. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200548 · Cited by 1 · see citing works

Association between multimorbidity and young-onset dementia: a prospective study

Chen, D., Zhang, M., Wen, Y., Han, H., Qin, Y., Zhang, R., Cao, H., & Yu, H. (2025) · BMC Public Health · doi:10.1186/s12889-025-25633-5

Association of triglyceride and cholesterol with vestibular vertigo: Evidence from univariable and multivariable mendelian randomization and mediation analysis

Mu, Y., Lu, Y., & Fu, W. (2026) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2025.101747

Association between remnant cholesterol and cardiac conduction block: A prospective cohort study

Li, X., Li, M., Cao, L., Shi, S., Zheng, N., Peng, S., Guan, B., Jiang, T., Liu, S., Tse, G., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.01.019

Association between remnant cholesterol and cardiometabolic multimorbidity in non-alcoholic fatty liver disease patients: evidence from a cross-sectional study

Xie, Y., Li, H., Xu, Y., Lv, D., Chu, J., Ye, J., & Huang, K. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04623-w

Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease

Wulff, A. B., Varbo, A., Nordestgaard, A. G., & Nordestgaard, B. G. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2639678 · Cited by 2 · see citing works

Association of pre-adolescent adverse childhood experiences with adolescent cholesterol levels: findings from the A-CHILD longitudinal study

Owusu, F. M., Nawa, N., Khin, Y. P., Nishimura, H., Doi, S. K., Isumi, A., & Fujiwara, T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1745206

Remnant Cholesterol and Incident Depression in Aging: A 14-Year Prospective Cohort Study and Mendelian Randomization Analysis

Qi, M., Wang, M., Li, Y., & Cai, X. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117170

A competitive fluorescence sensor based on AuNPs-β-CD and 1-(4-(1,2,2-triphenylvinyl) phenyl)pyrene for cholesterol detection

Liu, S. M., Zhang, Y., Zhao, H., Liu, J., & Hou, C. (2026) · Microchimica Acta · doi:10.1007/s00604-026-08055-x

Associations between lipid parameters and incident cardio-renal-metabolic multimorbidity: The Tehran Lipid and Glucose Study

Masrouri, S., Ebrahimi, N., Molavizadeh, D., Esmaeili, F., Azizi, F., & Hadaegh, F. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104805

Cumulative exposure and patterns of the cholesterol–HDL-C–glucose index and risk of new-onset cardiometabolic multimorbidity: 9-year longitudinal evidence from CHARLS

Li, S., Tao, L., Wu, D., F, X., & Luo, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1835874

Progress in Mendelian Randomization Studies on the Causal Association of GLM7 Index Components with Stroke

王, 一. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1652171

Cardiometabolic risk status modifies the associations between remnant cholesterol with incident diabetes: evidence from two East Asian cohorts

Li, Y., Chen, Z.-Y., Shang, L., Wang, Y.-H., Liu, X.-Y., Yang, Y.-H., & He, L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1770876

Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study

Rong, L., Fan, H.-D., Fang, Q., Li, X., Tan, J., & Huang, J. (2026) · Medicine · doi:10.1097/md.0000000000049157

Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model

Jiang, Y., Qian, A., Chen, S. H., Wu, Q., Xu, H., Zheng, C., Zhang, F., Xing, W., & He, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1874711

An intervention study of the general practice management of older adults with cardiovascular metabolic comorbidities

Li, Y., Zou, Z., Yi, S., Yang, Y., Yuan, G., & Xu, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350895

Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts incident hypertension: a 9-year prospective cohort study in Chinese adults

Wu, X.-F., S, C., Zhang, Y.-C., Liu, S., Yan, B., & Li, X. G. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06008-z

Higher remnant cholesterol inflammatory index is associated with increased frailty risk in the UK Biobank

Zhou, Q., Liu, M., Wang, L., Wang, P., Qin, Y., Zhao, M., Wanyan, T., Yu, J., Wan, Y., Zhang, Q. X., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1864976

Remnant cholesterol and incident metabolic syndrome: evidence from a prospective cohort with emphasis on individuals with normal triglyceride levels

Tang, S., & Tao, Y. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104862

Analytic codes for Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Zhao, Y. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10560861 · Cited by 1 · see citing works

Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis

Guan, B., Wang, A., & Xu, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01927-z · Cited by 50 · see citing works

Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality

Wadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac822 · Cited by 209 · see citing works

Remnant cholesterol and body mass index jointly associate with cardiometabolic Multimorbidity with mediation analysis in CHARLS a prospective cohort study

Li, J., Fan, M., Yang, M., Huang, W., Shi, W., Zhang, D., Zhu, W., Liu, C., Xu, N., Zhang, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25958-6 · Cited by 8 · see citing works

Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk

López-Miranda, J. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500822 · Cited by 1 · see citing works